Table 3.
Nutrition and immunity changes of participants enrolled in the program in relation to the Coping Strategies Index tertiles
| Coping Strategies Index categories | All | Not yet on ART | Started ART | ||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Median (IQR) | P value | n | Median (IQR) | P value | n | Median (IQR) | P value | |
| Weight gain at discharge (kg) | |||||||||
| Middle and best tertiles: ≥22.75 | 76 | 3.3 (−1.7 to 6.9) | 0.058 | 49 | 2.1 (−2.0 to 6.8) | 0.145 | 27 | 5.1 (1.6 to 7.2) | 0.681 |
| Worst tertile: <22.75 | 41 | 0.0 (−1.7 to 3.4) | 29 | −0.1 (−1.9 to 1.2) | 12 | 3.6 (−1.3 to 9.4) | |||
| BMI gain at discharge (kg/m2) | |||||||||
| Middle and best tertiles: ≥22.75 | 76 | 1.2 (−0.6 to 2.6) | 0.046 | 49 | 0.6 (−0.7 to 2.5) | 0.132 | 27 | 1.9 (0.6 to 2.7) | 0.626 |
| Worst tertile: <22.75 | 41 | 0.0 (−0.7 to 1.5) | 29 | 0.0 (−0.9 to 0.4) | 12 | 1.2 (−0.4 to 3.3) | |||
| MUAC gain at discharge (mm) | |||||||||
| Middle and best tertiles: ≥22.75 | 76 | 22.0 (−0.7 to 36.0) | 0.119 | 49 | 14.0 (−9.0 to 35.5) | 0.313 | 27 | 24.0 (14.0 to 38.0) | 0.563 |
| Worst tertile: <22.75 | 41 | 10.0 (−3.0 to 25.0) | 29 | 7.0 (−5.0 to 19.0) | 12 | 22.5 (5.5 to 35.2) | |||
| Hemoglobin gain at discharge (g/dL) | |||||||||
| Middle and best tertiles: ≥22.75 | 65 | 0.75 (−0.6 to 2.3) | 0.128 | 45 | 0.5 (−0.5 to 2.7) | 0.153 | 21 | 1.2 (−1.1 to 2.1) | 0.475 |
| Worst tertile: <22.75 | 36 | 0.37 (−1.0 to 1.4) | 25 | 0.2 (−1.1 to 1.4) | 11 | 0.4 (−0.8 to 1.8) | |||
| CD4 count gain at discharge (cells/μL) | |||||||||
| Middle and best tertiles: ≥22.75 | 49 | 43.0 (−20.0 to 127.0) | 0.595 | 33 | 9.0 (−29.0 to 88.0) | 0.718 | 16 | 100.0 (−42.0 to 183.7) | 0.692 |
| Worst tertile: <22.75 | 23 | 26.0 (−90.0 to 132.0) | 14 | 6.0 (−96.5 to 63.0) | 9 | 89.0 (−51.5 to 213.5) | |||
Abbreviations: ART, antiretroviral therapy; BMI, body mass index; IQR, interquartile range; MUAC, mid-upper arm circumference; SD, standard deviation.